FDA Approves First Oral Treatment for Postpartum Depression | FDA
The FDA approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults.| U.S. Food and Drug Administration
The FDA approved Zurzuvae (zuranolone), the first oral medication indicated to treat postpartum depression (PPD) in adults.| U.S. Food and Drug Administration
